Professor Tim Parkin to head up Bristol Vet School
Professor Tim Parkin.
Bristol alum and population medicine specialist Professor Tim Parkin has been announced as the new head of Bristol Veterinary School.
Professor Parkin, who graduated from Bristol in 1998, has an impressive repertoire of honours, awards and broad experience in the veterinary sphere.
As a specialist in population medicine within the European College of Veterinary Public Health, he is internationally renowned as the ‘go-to’ person when it comes to researching musculoskeletal disease and injury in the sports horse.
Commenting on his appointment, Professor Parkin said: “I am delighted and extremely proud to be returning to Bristol as Head of the Vet School. My whole career was shaped by my early experiences at the school and I relish the opportunity to inspire the current and future cohorts of students in a similar way.
“Working with colleagues at the school, I am sure we can continue the excellent progress that has been made over the last ten years.”
Professor Parkin joined the University of Glasgow as a Senior Fellow in Clinical Research in 2007 and was later appointed to Professor of Veterinary Epidemiology. He has co-authored 86 peer-reviewed publications and his final year course, 'Veterinary Public Health, Epidemiology and Population Medicine', has been described as ‘the best’ and ‘most interesting’ course across the Vet Bioscience programme.
Professor Jane Norman, Dean of the Faculty of Health Sciences said: “I am delighted to announce that Tim Parkin will be the next Head of Bristol Veterinary School. Tim is a Bristol graduate (twice) and brings a wealth of experience in population health and in veterinary research and education leadership roles.
“I look forward to working with Tim and veterinary school colleagues to build on Bristol’s continuing success over the next few years.”
The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.
